1. Antibiotics - Cell Envelope Flashcards
Penicillin - Available Drugs
Penicillin G - IV form
Penicillin V - PO
Prototype B-Lactam antibiotic
Penicillin - MOA
Bactericidal
- Bind penicillin binding proteins
- Block transpeptidase cross-linking of peptidoglycan
- Activate autolytic enzymes
Penicillin - Clinical Use
GRAM + = Strep. pneumonia, Strep. pyogenes, Actinomyces
- SYPHILIS
- Benzathine Penicillin G for prophylaxis for syphilis
Penicillin - Toxicities
Hypersensitivity rxn, hemolytic anemia.
Penicillin - Resistance
B-Lactamase cleaves the B-Lactam ring
Penicillinase Resistant Penicillins - Available Drugs
Methicillin
Nafcillin
Dicloxacillin
Penicillinase Resistant Penicillins (Methcillin, Nafcillin, Dicloxacillin) - MOA
Bactericidal
- Bind penicillin binding proteins
- Block transpeptidase cross-linking of peptidoglycan
- Activate autolytic enzymes
Penicillinase resistant due to bulkier R group
Penicillinase Resistant Penicillins (Methcillin, Nafcillin, Dicloxacillin) - Clinical Use
STAPH. aureus (not MRSA)
“use NAF for STAPH”
Penicillinase Resistant Penicillins (Methcillin, Nafcillin, Dicloxacillin) - Toxicities
Hypersensitivity rxn, methicillin-interstitial nephritis
Penicillinase Resistant Penicillins (Methcillin, Nafcillin, Dicloxacillin) - Resistance
MRSA resistant due to altered PBP target site.
Aminopenicillins - Available Drugs
Ampicillin
Amoxicillin
Aminopenicillins (Ampicillin, Amoxicillin) - MOA
Bactericidal
- Bind penicillin binding proteins
- Block transpeptidase cross-linking of peptidoglycan
- Activate autolytic enzymes
“AmOxicillin has better Oral bioavailability”
Aminopenicillins (Ampicillin, Amoxicillin) - Clinical Use
Haemophilus influenza E. coli Listeria monocytogenes Proteus mirabilis Salmonella Shigella Enterococci
“Aminopenicillins HELPSS kill ENTEROCOCCI”
Aminopenicillins (Ampicillin, Amoxicillin) - Toxicities
Hypersensitivity rxn, ampicillin rash, pseudomembranous collitis
Aminopenicillins (Ampicillin, Amoxicillin) - Resistance
B-Lactamase cleaves the B-Lactam ring
Antipseudomonal Penicillins - Available Drugs
Ticarcillin
Carbenicillin
Piperacillin
“TCP - Takes Care of Pseudomonas”
Antipseudomonal Penicillins (Ticarcillin, Carbenicillin, Piperacillin) - MOA
Bactericidal
- Bind penicillin binding proteins
- Block transpeptidase cross-linking of peptidoglycan
- Activate autolytic enzymes
Antipseudomonal Penicillins (Ticarcillin, Carbenicillin, Piperacillin) - Clinical Use
PSEUDOMONAS spp.
Gram (-) rods
Antipseudomonal Penicillins (Ticarcillin, Carbenicillin, Piperacillin) - Toxicities
Hypersensitivity rxn
B-Lactamase Inhibitors - Available Drugs
Clavulonic Acid
Sulbactam
Tazobactam
“CAST”
B-Lactamase Inhibitors (Clavulonic Acid, Sulbactam, Tazobactam) - MOA
Block activity of B-Lactamase / Penicillinase
B-Lactamase Inhibitors (Clavulonic Acid, Sulbactam, Tazobactam) - Clinical Use
Added to penicillin antibiotics to protect the drug from destruction by B-lactamase / Penicillinase
Cephalosporins - MOA
Bactericidal
- Bind penicillin binding proteins
- Block transpeptidase cross-linking of peptidoglycan
- Activate autolytic enzymes
1st Gen. Cephalosporins - Available Drugs
Cefazolin
Cephalexin
1st Gen. Cephalosporins (Cefazolin, Cephalexin) - Clinical Use
Gram (+) cocci
Proteus mirabilis
E. coli
Klebsiella pneumoniae
“PEcK”
2nd Gen. Cephalosporins - Available Drugs
Cefoxitin
Cefaclor
Cefuroxime
2nd Gen. Cephalosporins (Cefoxitin, Cefaclor, Cefuroxime) - Clinical Use
Gram (+) cocci Haemophilus influenzae Enterobacter aerogenes Neisseria spp. Proteus mirabilis E. coli Klebsiella pneumoniae Serratia marcescens
“HEN PEcKS”
3rd Gen. Cephalosporins - Available Drugs
Ceftriaxone
Cefotaxime
Ceftazidime
3rd Gen. Cephalosporins (Ceftriaxone, Cefotaxime, Ceftazidime) - Clinical Use
Serious Gram (-) infections resistant to other B-lactams.
- CEFTRIAXONE - MENINGITIS, GONORRHEA (treatment and prophylaxis)
CEFTAZIDIME - PSEUDOMONAS
4th Gen. Cephalosporins - Available Drugs
Cefepime
4th Gen. Cephalosporins (Cefepime) - Clinical Use
Increased activity against PSEUDOMONAS and Gram (+)’s
Cephalosporins - Toxicities
Hypersensitivity rxn (Cross sensitivity with penicillins in 5-10% of patients)
Vitamin K deficiency
Increases nephrotoxicity of aminoglycosides
Disulfiram-like rxn with EtOH
Cephalosporins - Resistance
Less susceptible to penicillinases than the penicillins.
Organisms not covered by Cephalosporins are LAME - Listeria Atypicals MRSA Enterococci
Aztreonam - MOA
Monobactam
Bind PBP3 –> Prevent cell wall synthesis
Aztreonam - Clinical Use
GRAM (-) RODS ONLY
For penicillin allergic or those with renal insufficiency who cannot tolerate aminoglycosides.
Aztreonam - Toxicities
Usually non-toxic
No cross sensitivity with penicillins or cephalosporins
Some GI upset
Aztreonam - Resistance
Resistant to B-lactamases
Carbapenams - Available Drugs
Imipenem(/Cilistatin) - Always given in combo
Meropenem
Carbapenams (Imipenam, Meropenam) - MOA
Bactericidal
- Bind penicillin binding proteins
- Block transpeptidase cross-linking of peptidoglycan
- Activate autolytic enzymes
Carbapenams (Imipenam, Meropenam) - Clinical Use
Gram (+) cocci
Gram (-) Rods
Anaerobes
Extremely wide spectrum but use limited by side effects.
Carbapenams (Imipenam, Meropenam) - Toxicities
GI distress
Skin rash
CNS toxicity - seizures - at high plasma levels - (Imipenam»_space; Meropenam)
Vancomycin - MOA
Bactericidal
“pay 2 Dalas (dollars) for VANdalizing”
Inhibit cell wall mucopeptide formation by binding D-ala D-ala portion of cell wall precursors.
Vancomycin - Clinical Use
GRAM (+) ONLY Serious multi-drug resistant organisms - S. aureus - MRSA - Enterococci (not VRE) - C. diff.
Vancomycin - Toxicities
"does NOT have many problems" Nephrotoxicity Ototoxicity Thrombophlebitis diffuse flushing - red man syndrome - prevent with pre-treatment with antihistamines and slower infusion rate
Vancomycin - Resistance
Change of D-ala D-ala to D-ala D-lac.
Cell Envelope Antibiotics - Available Drugs
Beta Lactams - Penicillins - Cephalosporins - Carbapenams - Monobactams (Aztreonam) - Beta Lactamase Inhibitors Vancomycin
Cilistatin - MOA
Inhibit renal dehydropeptidase I
Cilistatin - Clinical Use
Administered in combination with Imipenam to prevent degradation of Imipenam in renal tubules.